105135-96-4

Basic information

• Product Name: 2-Propyn-1-ol, 3-[4-(methylsulfonyl)phenyl]-
• CAS NO: 105135-96-4
• Molecular Formula: C10H10O3S
• Molecular Weight: 210.254
• Mol File: 105135-96-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-Propyn-1-ol, 3-[4-(methylsulfonyl)phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Propyn-1-ol, 3-[4-(methylsulfonyl)phenyl]-(105135-96-4)
• EPA Substance Registry System: 2-Propyn-1-ol, 3-[4-(methylsulfonyl)phenyl]-(105135-96-4)

Safety Data

• Hazardous Substances Data: 105135-96-4(Hazardous Substances Data)

Upstream product

• 64984-08-3 1-iodo-4-(methylsulfonyl)benzene 
• 107-19-7 propargyl alcohol 
• 104-95-0 (4-bromophenyl)thioanisole 
• 3466-32-8 4-bromoohenyl methyl sulfone 

Downstream Products

• 651310-29-1 3-[4-(methylsulfonyl)phenyl]propan-1-ol 
• 115475-66-6 [(2R,3S)-3-(4-Methanesulfonyl-phenyl)-oxiranyl]-methanol 
• 115475-65-5 (Z)-3-(4-Methanesulfonyl-phenyl)-prop-2-en-1-ol 

Relevant articles and documents

Novel valdecoxib derivatives by ruthenium?II)-promoted 1, 3-dipolar cycloaddition of nitrile oxides with alkynes - Synthesis and COX-2 inhibition activity

Novel valdecoxib-based cyclooxygenase-2 inhibitors were synthesized in one step via 1, 3-dipolar cycloaddition of nitrile oxides with a series of eleven aryl alkynes, six of them described for the first time. Application of Ru?II)-catalysis leads preferab

5-Substituted isoquinoline derivatives

A compound represented by the following formula (1) or a salt thereof: wherein R1 represents hydrogen atom, a halogen atom and the like; R2 represents hydrogen atom, a halogen atom, a C1-6 alkyl group and the like; and R3 represents —O—X—C(A1)(A11)—C(A2)(A2l)—N(A3l)(A3)(X represents propylene group etc., A11 and A21 represent hydrogen atom, or a C1-6 alkyl group, A31 represents a C1-6 alkyl group substituted with hydroxyl group, or hydrogen atom, and A1, A2, and A3 represent hydrogen atom, a C1-6 alkyl group and the like) and the like, which has an inhibitory activity on the phosphorylation of myosin regulatory light chain, and is useful for treatment of diseases relating to contraction of various cells and the like.